Clinical implications of species identification in monomicrobial Aeromonas bacteremia.

Chi-Jung Wu, Po-Lin Chen, Po-Ren Hsueh, Ming-Chung Chang, Pei-Jane Tsai, Hsin-I Shih, Hsuan-Chen Wang, Pei-Hsin Chou, Wen-Chien Ko
Author Information
  1. Chi-Jung Wu: National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan, Taiwan; Institute of Clinical Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan; Departments of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
  2. Po-Lin Chen: Institute of Clinical Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan; Departments of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
  3. Po-Ren Hsueh: Departments of Laboratory Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan; Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
  4. Ming-Chung Chang: Biochemistry and Molecular Biology Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan.
  5. Pei-Jane Tsai: Medical Laboratory Science and Biotechnology, National Cheng Kung University College of Medicine, Tainan, Taiwan.
  6. Hsin-I Shih: Emergency Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
  7. Hsuan-Chen Wang: National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan, Taiwan.
  8. Pei-Hsin Chou: National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan, Taiwan.
  9. Wen-Chien Ko: Departments of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan; Departments of Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan.

Abstract

BACKGROUND: Advances in Aeromonas taxonomy have led to the reclassification of aeromonads. Hereon, we aimed to re-evaluate the characteristics of Aeromonas bacteremia, including those of a novel species, Aeromonas dhakensis.
METHODOLOGY/PRINCIPAL FINDINGS: A retrospective study of monomicrobial Aeromonas bacteremia at a medical center in southern Taiwan from 2004-2011 was conducted. Species identification was based on rpoB sequencing. Of bacteremia of 153 eligible patients, A. veronii (50 isolates, 32.7%), A. dhakensis (48, 31.4%), A. caviae (43, 28.1%), and A. hydrophila (10, 6.5%) were the principal causative species. A. dhakensis and A. veronii bacteremia were mainly community-acquired and presented as primary bacteremia, spontaneous bacterial peritonitis, or skin and soft-tissue infection, whereas A. caviae was associated with hospital-onset bacteremia. The distribution of the AmpC β-lactamase and metallo-β-lactamase genes was species-specific: bla(AQU-1), bla(MOX), or bla(CepH) was present in A. dhakensis, A. caviae, or A. hydrophila, respectively, and bla(CphA) was present in A. veronii, A. dhakensis, and A. hydrophila. The cefotaxime resistance rates of the A. caviae, A. dhakensis, and A. hydrophila isolates were higher than that of A. veronii (39.5%%, 25.0%, and 30% vs. 2%, respectively). A. dhakensis bacteremia was linked to the highest 14-day sepsis-related mortality rate, followed by A. hydrophila, A. veronii, and A. caviae bacteremia (25.5%, 22.2%, 14.0%, and 4.7%, respectively; P = 0.048). Multivariate analysis revealed that A. dhakensis bacteremia, active malignancies, and a Pitt bacteremia score ≥ 4 was an independent mortality risk factor.
CONCLUSIONS/SIGNIFICANCE: Characteristics of Aeromonas bacteremia vary between species. A. dhakensis prevalence and its associated poor outcomes suggest it an important human pathogen.

References

  1. J Infect. 2000 May;40(3):267-73 [PMID: 10908022]
  2. PLoS One. 2014;9(11):e111213 [PMID: 25375798]
  3. Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1511-9 [PMID: 15388703]
  4. Clin Infect Dis. 1994 Jul;19(1):77-83 [PMID: 7948561]
  5. Antimicrob Agents Chemother. 1995 Feb;39(2):346-9 [PMID: 7726495]
  6. Clin Infect Dis. 1995 May;20(5):1298-304 [PMID: 7620014]
  7. J Antimicrob Chemother. 1997 Aug;40(2):171-8 [PMID: 9301981]
  8. Int J Antimicrob Agents. 1999 Jan;11(1):7-12 [PMID: 10075272]
  9. Int J Syst Evol Microbiol. 2006 Dec;56(Pt 12):2743-51 [PMID: 17158971]
  10. Int J Syst Evol Microbiol. 2008 May;58(Pt 5):1169-75 [PMID: 18450708]
  11. J Clin Microbiol. 2009 Nov;47(11):3742-6 [PMID: 19741075]
  12. Clin Microbiol Rev. 2010 Jan;23(1):35-73 [PMID: 20065325]
  13. Can J Microbiol. 2010 Mar;56(3):217-28 [PMID: 20453908]
  14. J Clin Microbiol. 2011 Aug;49(8):3006-8 [PMID: 21697316]
  15. J Korean Med Sci. 2011 Nov;26(11):1415-20 [PMID: 22065896]
  16. Antimicrob Agents Chemother. 2011 Dec;55(12):5813-8 [PMID: 21968366]
  17. PLoS One. 2012;7(2):e30205 [PMID: 22383958]
  18. J Med Microbiol. 2012 May;61(Pt 5):712-9 [PMID: 22322339]
  19. Diagn Microbiol Infect Dis. 2012 Dec;74(4):406-8 [PMID: 22995364]
  20. Syst Appl Microbiol. 2013 May;36(3):171-6 [PMID: 23485124]
  21. Diagn Microbiol Infect Dis. 2013 May;76(1):106-9 [PMID: 23461831]
  22. Int J Antimicrob Agents. 2013 Nov;42(5):456-61 [PMID: 24055254]
  23. J Clin Microbiol. 2014 Jul;52(7):2625-8 [PMID: 24759711]
  24. Clin Microbiol Infect. 2014 Jul;20(7):O428-34 [PMID: 24237662]
  25. Pathol Biol (Paris). 2003 Jul;51(5):290-6 [PMID: 14567197]

MeSH Term

Adult
Aeromonas
Aged
Anti-Bacterial Agents
Bacteremia
Bacterial Proteins
Comorbidity
Female
Gram-Negative Bacterial Infections
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Retrospective Studies
Treatment Outcome
beta-Lactamases

Chemicals

Anti-Bacterial Agents
Bacterial Proteins
AmpC beta-lactamases
beta-Lactamases

Word Cloud

Created with Highcharts 10.0.0bacteremiadhakensisAeromonasveroniicaviaehydrophilaspeciesblarespectivelymonomicrobialidentificationisolates7%5%associatedpresent250%2%mortality4BACKGROUND:AdvancestaxonomyledreclassificationaeromonadsHereonaimedre-evaluatecharacteristicsincludingnovelMETHODOLOGY/PRINCIPALFINDINGS:retrospectivestudymedicalcentersouthernTaiwan2004-2011conductedSpeciesbasedrpoBsequencing153eligiblepatients503248314%43281%106principalcausativemainlycommunity-acquiredpresentedprimaryspontaneousbacterialperitonitisskinsoft-tissueinfectionwhereashospital-onsetdistributionAmpCβ-lactamasemetallo-β-lactamasegenesspecies-specific:AQU-1MOXCepHCphAcefotaximeresistancerateshigher395%%30%vslinkedhighest14-daysepsis-relatedratefollowed2214P=0048MultivariateanalysisrevealedactivemalignanciesPittscoreindependentriskfactorCONCLUSIONS/SIGNIFICANCE:CharacteristicsvaryprevalencepooroutcomessuggestimportanthumanpathogenClinicalimplications

Similar Articles

Cited By